Anh Ngo

Anh Ngo is a highly accomplished professional in the fields of venture capital and healthcare innovation, currently serving as a Venture Partner at NextGen Venture Partners since 2019. Concurrently, Anh holds memberships at Mass Medical Angels and the International Neuromodulation Society, and contributes to the Neuromodulation Journal as a peer review board member. With extensive experience at Ideaing as an investor and executive, and as an editorial member for Blockchain in Healthcare Today, Anh combines expertise in smart technology and blockchain applications in healthcare. Prior roles include co-coordinator for Healthcare Innovation & Commercialization at Harvard Medical School, investment fellow at Ascentia Asset Management, and ceo co-founder of Irvine Capital. Anh's medical background includes serving as an anesthesiologist at Beth Israel Deaconess Medical Center and partnership in a large medical practice management company. Educational qualifications comprise advanced degrees in medicine and business from prestigious institutions, including Harvard Medical School and UC Irvine.